# Investigator Initiated Clinical Trials (IICT)

**Funder:** SNSF
**Deadline:** 3 November 2026 (Full proposal due 3 November 2026, 17:00 Swiss local time. Letter of intent due 26 May 2026, 17:00 Swiss local time (past). PPI Preparatory Grant (up to CHF 5,000) also due 26 May 2026.)
**Application:** 2-stage: letter of intent (26 May 2026) → full proposal (3 November 2026)
**Frequency:** Annual
**Eligible countries:** CH
**Official call:** https://www.snf.ch/en/hyaJhBlfsmd618fO/funding/programmes/iict
**Last verified:** 12 July 2026

## Eligibility & scope

Supports investigator-initiated randomised controlled clinical trials (RCTs) addressing unmet medical/societal needs, not in industry focus. Requires a multicentric setting; research group of up to 5 persons with strong track record. Excludes pilot, proof-of-concept (phase I/IIa), observational, and commercial studies. CV and research plan must be in the language of the research plan; CTU involvement highly recommended.

## Summary

SNSF's Investigator Initiated Clinical Trials (IICT) fund multicentric randomised controlled trials addressing unmet medical or societal needs, open to Swiss-based research teams with a strong track record. The call excludes pilot, proof-of-concept, and observational studies, and expects involvement of a Clinical Trial Unit. Annual deadline in November.

## Who should apply

- Swiss-based research teams with a strong publication and trial track record
- Investigators leading multicentric randomised controlled trials
- Teams planning to partner with a Clinical Trial Unit
- Researchers addressing unmet clinical or societal needs outside industry focus

## Key dates

- Letter of intent due 26 May 2026, 17:00 Swiss local time (deadline passed)
- Full proposal due 3 November 2026, 17:00 Swiss local time
- Two-stage evaluation: letter of intent then full proposal

## Tips for applicants

- Clinical Trial Unit involvement is highly recommended; a named CTU partner strengthens feasibility and implementation scoring.
- The research group is capped at 5 persons, demonstrate why each member is essential and outline their role in trial management.
- Ensure your proposal and CV are in the same language as your research plan; mixed languages trigger desk rejection.

## Frequently asked questions

### What types of clinical trials does SNSF IICT fund?

SNSF funds investigator-initiated, multicentric randomised controlled trials (RCTs) addressing unmet medical or societal needs. Pilot, proof-of-concept, observational, and commercial studies are not eligible.

### Who is eligible to apply for SNSF IICT?

Swiss-based research teams with a strong track record, working on trials that are not in industry focus. Teams must operate in a multicentric setting and may include up to 5 research group members.

### What is the SNSF IICT letter of intent deadline?

The letter of intent was due 26 May 2026; the full proposal deadline is 3 November 2026, 17:00 Swiss local time.

### Is a Clinical Trial Unit required for SNSF IICT?

CTU involvement is highly recommended, though not formally mandatory. It strengthens the proposal's feasibility and implementation plan.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/snsf-investigator-initiated-clinical-trials-iict-2026-11) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md).